SB 480

Hawaii Senate bill in Session 2026.

Status: failed. Latest action: February 10, 2025.

Department of Health; Affordable Health Care; Prescription Drugs; 340B Drug Pricing Program; Pharmacies; Covered Entities; Discriminatory Practices.

Bill ID HI-2026-SB-480

Session 2026

Status failed

Committee HHS, CPN/JDC

Senate failed 2025-02-10

Business / Commerce Healthcare

Summary

Prohibits drug manufacturers and wholesale distributors from restricting or denying access for pharmacies contracted with 340B covered entities to purchase 340B drugs at a discounted price under the federal 340B Drug Pricing Program. Imposes civil penalties for engaging in unfair or deceptive acts or practices in the conduct of any trade or commerce.

Sponsor

Joy A. San Buenaventura

Official Source Back to Bills

Actions Timeline

Date	Event	Detail
0000-00-00	Introduced	Bill introduced
2025-02-10	Status	failed
2025-02-10	Latest Action	The committee on HHS deferred the measure.

More Bills From This Sponsor

SB 847 SD2 HD2 CD1

SHPDA; Board of Psychology; Prescriptive Authority; Clinical Psychologists; Pilot Program; Supervising Physician or Psychiatrist; Federally Qualified Health Centers; County of Kauai; County of Hawaii; Rules; Report

enacted • Senate

SB 2851 SD1 HD2 CD1

Deaf; Hearing Impaired; Disability; Motor Vehicle Registration; Law Enforcement

enacted • Senate

SB 3234 SD2 HD1 CD1

DOT; Safe Routes to School; Pedestrian Safety Improvements; Appropriation

enacted • Senate

SB 3001 SD2 HD3 CD1

DCCA; Attorney General; Office of Consumer Protection; DOH; Artificial Intelligence; AI Companions; Disclosures; Protections; Minors; UDAP; Reports

enacted • Senate

SB 2259 SD1 HD1 CD1

DBEDT; Hawaii Dementia Initiative Business Recognition Program; Establishment; Appropriation

enacted • Senate

SB 2031 SD2 HD1 CD1

Consumer Protection; Unfair or Deceptive Acts or Practices; Live-Event Tickets; Short-Term Lodging; Disclosures; Total Price; Junk Fees; Federal Rule on Unfair or Deceptive Fees

enacted • Senate